The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 69.00
High: 70.00
Low: 69.00
Prev. Close: 69.00
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re ProReveal

24 Jul 2013 07:01

RNS Number : 9861J
Scientific Digital Imaging Plc
24 July 2013
 

Scientific Digital Imaging Plc

 

Scientific Digital Imaging's ProReveal to be used to train professionals

at Eastwood Park

 

Cambridge, UK 24 July 2013: Scientific Digital Imaging (AIM: SDI, "SDI" or the "Company"), the AIM quoted group focused on the application of digital imaging technology to the needs of the scientific community, is pleased to announce that the major international healthcare training centre, Eastwood Park, UK will be using ProReveal, a test to detect proteins on surgical instruments, to supplement the training of validation professionals on how to assess the efficacy of the decontamination processes.

 

The highly sensitive ProReveal, developed by SDI's Synoptics Health Division, is an in-situ fluorescence test which can detect nanogram levels of protein. It will be used on decontamination courses (compliant with EU and UK guidelines), to train senior personnel from UK and international decontamination validation and sterile services departments (SSDs).

 

Bruce Garbutt, Training Consultant at Eastwood Park said: "Protein decontamination is the ultimate in cleaning efficacy. If your process has removed protein you know your surgical instruments can be made safe to re-use. It is possible to infect patients with prion diseases like vCJD if the cleaning processes are not optimal and we have begun to realise how swab tests to detect prion levels can be flawed, hence the imperative for an 'in situ' test such as ProReveal."

 

Paul Ellwood, SDI Synoptics Health's CEO concluded: "Eastwood Park is a very progressive training centre and their adoption of the ProReveal test shows that they are preparing decontamination professionals to comply with the new quality standards. Their commitment to improving their decontamination processes will ensure professionals will be able to quickly and easily implement the ProReveal technology in their own facilities, to easily meet the upcoming minimum safe residual protein contamination guideline level being set by the Department of Health."

 

-Ends-

For Further Information Contact:

 

Scientific Digital Imaging:

 

Mike Creedon, Chief Executive of SDI - 01223 727144

Paul Ellwood, Chief Executive of Synoptics Health - 01223 727129

 

JW Communications

Julia Wilson, Investor & Public Relations - 0781 8430877

 

finnCap - 020 7220 0500

 

Ed Frisby/Rose Herbert -Corporate Finance

Simon Starr -Corporate Broking

 

 

 

Note to Editors

 

Scientific Digital Imaging Plc

Scientific Digital Imaging plc (SDI) is focused on the application of digital imaging technology to the needs of the scientific and technology community. Its principal subsidiary is Synoptics Limited, which designs and manufactures special-purpose instruments for use mainly in the life sciences, supplying customers in the academic, research and health sectors. Within Synoptics, the recently formed Synoptics Health division has launched the Synoptics Health ProReveal system. This patented system offers a highly sensitive fluorescence-based test to detect dirty surgical instruments in hospitals and aims to reduce incidences of cross contamination of patients. In addition, under the Atik brand, SDI designs and manufactures high-sensitivity cameras for both astronomical and life science applications. www.scientificdigitalimaging.com

 

 

Eastwood Park

 

Eastwood Park in Gloucestershire, UK is widely acknowledged as a leading training centre, with an international reputation. It delivers specialist medical equipment, engineering, decontamination, facilities management and estates training, primarily to the healthcare and commercial facilities management sectors.

 

Most of the training offered is unique and is accredited by internationally recognised Awarding Bodies. Courses are regularly updated and new courses developed responding to new technologies, the latest official guidelines and individual sector developments.

 

Established 40 years, Eastwood Park maintains its commitment to delivering quality training as much today as the day it started in this vital sector.

www.eastwoodparktraining.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUORNROUABUAR
Date   Source Headline
21st Sep 20227:00 amRNSAGM Trading Update
24th Aug 20227:00 amRNSPosting of Annual Report and Notice of AGM
1st Aug 20227:00 amRNSAcquisition of LTE Scientific Limited
28th Jul 20227:00 amRNSBoard Appointment
21st Jul 20227:00 amRNSFinal Results
19th Jul 20222:20 pmRNSNotice of Results and Investor Presentation
30th Jun 20227:00 amRNSBoard Changes
6th May 20229:08 amRNSSecond Price Monitoring Extn
6th May 20227:00 amRNSTrading Update
26th Apr 20225:20 pmRNSChange of Website
28th Mar 20227:00 amRNSAcquisition of Safelab Systems Limited and TVR
18th Mar 20221:10 pmRNSExercise of Share Options and Total Voting Rights
14th Jan 20222:40 pmRNSResult of Secondary Placing
14th Jan 20221:30 pmRNSSecondary Placing, Exercise of Options & TVR
11th Jan 20227:00 amRNSBoard Change
7th Jan 20227:00 amRNSAcquisition of SVS and Atik Order
17th Dec 202112:10 pmRNSExercise of Share Options and Total Voting Rights
7th Dec 20217:00 amRNSInterim Results
12th Nov 20217:00 amRNSInvestor Presentation
4th Nov 20217:00 amRNSTrading Update and Notice of Results
15th Oct 202112:45 pmRNSHolding(s) in Company
1st Oct 20215:15 pmRNSTotal Voting Rights
1st Oct 202112:45 pmRNSLong Term Incentive Plan Awards
23rd Sep 202111:15 amRNSHolding(s) in Company
22nd Sep 20214:28 pmRNSResult of AGM
22nd Sep 20217:00 amRNSAGM Trading Update
3rd Sep 202111:30 amRNSExercise of Options, Director Shareholding and TVR
26th Aug 20219:45 amRNSHolding(s) in Company
23rd Aug 202111:45 amRNSPosting of Annual Report and Notice of AGM
20th Jul 20217:00 amRNSFinal Results
1st Jul 20214:30 pmRNSTotal Voting Rights
23rd Jun 20217:00 amRNSInvestor Presentation
10th Jun 202112:45 pmRNSHolding(s) in Company
27th May 20215:30 pmRNSExercise of Options, Director Shareholding & TVR
26th May 20216:15 pmRNSDirector Dealing
26th May 20217:00 amRNSTrading Update
12th May 20217:00 amRNSNotice of Results
26th Apr 20219:25 amRNSExercise of Options and Total Voting Rights
14th Apr 20214:26 pmRNSExercise of Options and Total Voting Rights
14th Apr 20214:16 pmRNSDirector Dealing
6th Apr 20213:50 pmRNSExercise of Options and Total Voting Rights
1st Apr 20213:13 pmRNSDirector Dealing
3rd Mar 20212:19 pmRNSHolding(s) in Company
2nd Mar 20214:53 pmRNSHolding(s) in Company
22nd Feb 20214:41 pmRNSHolding(s) in Company
10th Feb 20214:05 pmRNSHolding(s) in Company
10th Feb 20219:06 amRNSSecond Price Monitoring Extn
10th Feb 20219:03 amRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSTrading Update
1st Feb 20217:00 amRNSAcquisition of Uniform Engineering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.